Sinopharm en las noticias
Distribución e investigación farmacéutica
Tamtam encontró 20 artículos recientes sobre Sinopharm.
- Sinopharm Group (SEHK:1099) Stock Can Q3 Earnings Turn Revenue Into Profit
- ETFs Investing in Sinopharm Group Co., Ltd. Unsponsored ADR Class H Stocks
- Sinopharm Group Co. Ltd. Advanced Charts | 1099
- Harbour BioMed and Sinopharm Form Strategic Alliance to Accelerate Innovative Biologics
- Harbour BioMed and Sinopharm Will Establish R&D ‘Innovation Consortium’
- Harbour BioMed and Sinopharm Form R&D Consortium to Advance Biologics Development
- Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
- Tsinghua University - Sinopharm Joint Research Institute unveiled, first meeting held
- UM, Sinopharm establish cooperation in biomedical sciences – Macao SAR Government Portal
- The Prevalence of Side Effects of Sinopharm COVID-19 Vaccine: An Experience From Pakistan
- Pfizer signs strategic cooperation pact with China's Sinopharm
- G42 and Sinopharm launch world’s first phase III clinical trial of Covid-19 vaccine
- G42 announces new JV with Sinopharm CNBG to produce Hayat-Vax vaccine in the UAE
- The Sinopharm COVID-19 vaccine: What you need to know
- Sinopharm COVID-19 booster weaker against Omicron - study
- 200,000 Doses Of Sinopharm COVID-19 Vaccine Arrive From China
- UNICEF firma accordo per la fornitura del vaccino anti-COVID di Sinopharm
- Chinese Sinopharm And Sinovac Vaccines To Replenish Global COVAX Facility Supplies
- Morocco’s Sothema to produce China’s Sinopharm vaccine
- 200,000 Sinopharm vaccines arrive in Montenegro
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Sinopharm?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares